BTIG analyst Gray Powell initiates coverage on IronNet (NYSE:IRNT) with a Neutral rating.
Credit Suisse Maintains Neutral on BioAtla, Raises Price Target to $8
Credit Suisse analyst Tiago Fauth maintains BioAtla (NASDAQ:BCAB) with a Neutral and raises the price target from $4 to $8.